Testosterone/Anastrazole

睾酮/阿那曲唑

Report date: 2025/12/03 10:14:34

Base Information

Drug NameTestosterone/Anastrazole
Drug Alias NameTestosterone and anastrozole subcutaneous pelletCLAR-121HAV-088HAVAH T+Ai™T+Ai™
ClassificationSmall molecules > Steroids
Mechanisms of ActionAromatase inhibitorsTestosterone replacementsAndrogen Receptor agonists
TargetsAromataseAndrogen Receptor
Therapy Area/IndicationsBreast DiseasesBreast NeoplasmsCarcinoma, Intraductal, Noninfiltrating
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes TestosteroneAnastrozole
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHavah Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsCarcinoma, Intraductal, Noninfiltrating
Inactive IndicationsBreast Diseases

Other Information

ATC CodeN/A
Related LinksN/A